(WAY) Waystar Holding Common - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9467841055
WAY: Cloud-Based, Software, Healthcare, Payments, Financial,
Waystar Holding Corp. specializes in developing cloud-based software solutions tailored for healthcare payment management. Its platform streamlines financial operations through modules such as financial clearance, patient financial care, and claims management, enhancing efficiency for healthcare providers. The company, established in 2017 and based in Lehi, Utah, serves a broad spectrum of healthcare entities, including hospitals and medical groups.
The platforms capabilities extend to denial prevention, revenue capture, and comprehensive analytics, providing users with actionable insights to optimize their financial workflows. Waystars solutions are designed to integrate with existing healthcare information systems, ensuring seamless data flow and reducing administrative burdens.
Ticker: WAY is listed on the NASDAQ exchange, categorizing under Health Care Technology. With a market capitalization of $4.474 billion, the company reflects substantial market presence despite its relatively recent inception.
From a technical standpoint, WAYs stock exhibits a 20-day average volume of 1,418,050 shares, with a last price of $37.02. The SMA 20, 50, and 200 are $36.59, $38.68, and $32.25, respectively, indicating recent price stability. The ATR of 1.71 suggests moderate volatility.
Fundamentally, WAYs return on equity stands at -0.62, highlighting current profitability challenges. The absence of P/E and P/S metrics may indicate the companys focus on growth over immediate returns, a common strategy in the software sector.
3-Month Forecast: Based on the SMA trends, WAY may face resistance around $38.68, with support near $32.25. The ATR suggests price fluctuations within a $1.71 range. Fundamentally, while the negative RoE raises concerns, the companys market cap and industry position suggest potential for recovery and growth, contingent on improving profitability metrics.
Additional Sources for WAY Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
WAY Stock Overview
Market Cap in USD | 6,827m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Technology |
IPO / Inception | 2024-06-07 |
WAY Stock Ratings
Growth Rating | 48.3 |
Fundamental | 30.1 |
Dividend Rating | 0.0 |
Rel. Strength | 104 |
Analysts | 4.56/5 |
Fair Price Momentum | 46.55 USD |
Fair Price DCF | 15.31 USD |
WAY Dividends
No Dividends PaidWAY Growth Ratios
Growth Correlation 3m | -68.2% |
Growth Correlation 12m | 90.9% |
Growth Correlation 5y | 90.9% |
CAGR 5y | 96.52% |
CAGR/Max DD 5y | 4.20 |
Sharpe Ratio 12m | 1.23 |
Alpha | 83.96 |
Beta | 0.885 |
Volatility | 36.36% |
Current Volume | 2188.3k |
Average Volume 20d | 1298k |
As of May 05, 2025, the stock is trading at USD 40.68 with a total of 2,188,308 shares traded.
Over the past week, the price has changed by +11.03%, over one month by +16.46%, over three months by -0.93% and over the past year by +96.52%.
Neither. Based on ValueRay Fundamental Analyses, Waystar Holding Common is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 30.05 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WAY as of May 2025 is 46.55. This means that WAY is currently undervalued and has a potential upside of +14.43% (Margin of Safety).
Waystar Holding Common has received a consensus analysts rating of 4.56. Therefor, it is recommend to buy WAY.
- Strong Buy: 5
- Buy: 4
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, WAY Waystar Holding Common will be worth about 52.9 in May 2026. The stock is currently trading at 40.68. This means that the stock has a potential upside of +30.14%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 48.2 | 18.4% |
Analysts Target Price | 30.3 | -25.6% |
ValueRay Target Price | 52.9 | 30.1% |